From: Asthma and obesity: mechanisms and clinical implications
| Mechanical or physiologic effects | Lung function | • Restriction or reduced total lung capacity and decreased expiratory reserve volume |
| • Ventilation and perfusion mismatch | ||
| Airways Changes | • Bronchial hyperresponsiveness | |
| • Loss of beep breath induced bronchodilation | ||
| • Reduced exhaled NO (certain phenotypes) | ||
| Immune and metabolic effects | Immune function | • Decreased airway eosinophils (lumen, sputum) |
| • Increased airway neutrophils | ||
| • Predominately Th-1 related inflammation versus Th-2 | ||
| • Potential IL-17 related inflammation | ||
| • Enhanced inflammatory/oxidative response to elevated leptin levels | ||
| Metabolic function | • Higher plasma and airway leptin levels with reduced airway leptin receptors | |
| • Leptin receptors in visceral fat and relationship with bronchial hyperresponsiveness | ||
| • Leptin may increase oxidative stress levels | ||
| • Effect of adiponectin remains unclear | ||
| • Lower L-arginine/ADMA ratio and increase in oxidative stress resulting in an impaired bronchial dilatory response |